爱尔兰生物技术公司GH Research PLC在周三盘中出现大跌,股价下跌5.61%,引起了市场的广泛关注。
下跌原因主要是公司在周二晚些时候以15美元的价格发行了1000万股新股,总融资金额为1.5亿美元,用于支持其抑郁症疗法GH001和其他产品的研发。新股发行价格较前一交易日收盘价折价8.1%,导致股价在次日盘中大幅下挫。
尽管GH001在近期的中期临床研究中达到了主要目标,公司股价在上周一曾大涨70%至17.99美元的历史新高,但此次股权融资的定价给投资者带来了一定压力。市场对公司的估值存在分歧,未来走势或取决于产品管线的进一步进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.